BRISTOL MYERS SQUIBB CO
Data quality: 100%
CELG-RI
NYSE
Manufacturing
Chemicals
$0.09
▼
$0.01
(-9.09%)
Mkt Cap: 201.86 M
Price
$0.10
Mkt Cap
201.86 M
Day Range
—
52-Week Range
—
Volume
—
Open —
50D / 200D Avg
—
50D / 200D Avg
—
Quick Summary
Key Takeaways
Revenue grew 0.96% annually over 5 years — modest growth
ROE of 39.20% indicates high profitability
Debt/Equity of 2.87 — high leverage
Generating 12.85 B in free cash flow
P/E of 0.03 — trading at a low valuation
PEG of 0.14 suggests growth is underpriced
Growth
Revenue Growth (5Y)
0.96%
Below sector avg (1.82%)
Revenue (1Y)-0.22%
Earnings (1Y)N/A
FCF Growth (3Y)0.76%
Quality
Return on Equity
39.20%
Above sector avg (-53.34%)
ROICN/A
Net Margin14.64%
Op. MarginN/A
Safety
Debt / Equity
2.87
Above sector avg (0.31)
Current Ratio1.27
Interest CoverageN/A
Valuation
PE (TTM)
0.03
Above sector avg (-1.47)
P/B Ratio0.01
EV/EBITDAN/A
Dividend YieldN/A
Price History
Financial Trends
Peer Comparison
vs Manufacturing sector median (1364 peers)
Peer Comparison
vs Manufacturing sector median (1364 peers)| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 0.0 | -1.5 |
| P/B | 0.0 | 1.6 |
| ROE % | 39.2 | -53.3 |
| Net Margin % | 14.6 | -41.5 |
| Rev Growth 5Y % | 1.0 | 1.8 |
| D/E | 2.9 | 0.3 |
Analyst Price Target
No analyst coverage available
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2026 |
$3.55
N/A – N/A
|
48.66 B | — |
No quarterly estimates available
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -0.22% | Revenue Growth (3Y) | 3.48% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | -6.24% |
| Revenue Growth (5Y) | 0.96% | Earnings Growth (5Y) | 0.21% |
| Profitability | |||
| Revenue (TTM) | 48.19 B | Net Income (TTM) | 7.05 B |
| ROE | 39.20% | ROA | 7.36% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | 14.64% | Free Cash Flow (TTM) | 12.85 B |
| ROIC | N/A | FCF Growth (3Y) | 0.76% |
| Safety | |||
| Debt / Equity | 2.87 | Current Ratio | 1.27 |
| Interest Coverage | N/A | Asset Turnover | 0.50 |
| Working Capital | 7.49 B | Tangible Book Value | -23.66 B |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 0.03 | Forward P/E | N/A |
| P/B Ratio | 0.01 | P/S Ratio | 0.00 |
| PEG Ratio | 0.14 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | 6363.29% | ||
| Market Cap | 201.86 M | Enterprise Value | 37.70 B |
| Per Share | |||
| EPS (Diluted TTM) | 3.46 | Revenue / Share | 23.64 |
| FCF / Share | 6.30 | OCF / Share | 6.94 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | 2.62% |
| EPS CAGR (10Y) | 3.01% | ||
| Efficiency | |||
| CapEx / Revenue | 2.72% | FCF Conversion | 182.10% |
| SBC-Adj. FCF | 12.30 B | Growth Momentum | -1.18 |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 48.19 B | 48.30 B | 45.01 B | 46.16 B | 46.39 B |
| Net Income | 7.05 B | -8.95 B | 8.03 B | 6.33 B | 6.99 B |
| EPS (Diluted) | 3.46 | -4.41 | 3.86 | 2.95 | 3.12 |
| Gross Profit | — | — | — | — | — |
| Operating Income | — | — | — | — | — |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 9.95 B | 11.16 B | 9.30 B | 9.51 B | 11.35 B |
| SG&A Expenses | 7.27 B | 8.41 B | 7.77 B | 7.81 B | 7.69 B |
| D&A | 4.01 B | 9.60 B | 9.76 B | 10.28 B | 10.69 B |
| Interest Expense | 1.89 B | 1.95 B | 1.17 B | 1.23 B | 1.33 B |
| Income Tax | 2.27 B | 554.00 M | 400.00 M | 1.37 B | 1.08 B |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 90.04 B | 92.60 B | 95.16 B | 96.82 B | 109.31 B |
| Total Liabilities | 71.53 B | 76.22 B | 65.67 B | 65.70 B | 73.31 B |
| Shareholders' Equity | 18.47 B | 16.34 B | 29.43 B | 31.06 B | 35.95 B |
| Total Debt | 47.09 B | 51.48 B | 42.65 B | 43.22 B | 49.32 B |
| Cash & Equivalents | 10.21 B | 10.35 B | 11.46 B | 9.12 B | 13.98 B |
| Current Assets | 29.39 B | 29.78 B | 31.77 B | 27.27 B | 33.26 B |
| Current Liabilities | 23.42 B | 23.77 B | 22.26 B | 21.89 B | 21.87 B |
{"event":"ticker_viewed","properties":{"ticker":"CELG-RI","listing_kind":"stock","pathname":"/stocks/celg-ri","exchange":"NYSE","country":"US"}}